Crossmark Global Holdings Inc. increased its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 22.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 523,243 shares of the business services provider's stock after purchasing an additional 95,036 shares during the quarter. Crossmark Global Holdings Inc. owned approximately 0.30% of Genpact worth $21,919,000 at the end of the most recent reporting period.
A number of other large investors also recently added to or reduced their stakes in G. Dimensional Fund Advisors LP increased its holdings in shares of Genpact by 8.7% in the third quarter. Dimensional Fund Advisors LP now owns 3,978,210 shares of the business services provider's stock worth $166,651,000 after purchasing an additional 319,861 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Genpact by 17.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,762,407 shares of the business services provider's stock worth $157,609,000 after acquiring an additional 549,117 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Genpact by 2.5% during the 2nd quarter. Geode Capital Management LLC now owns 3,645,967 shares of the business services provider's stock worth $160,480,000 after acquiring an additional 90,541 shares in the last quarter. Tandem Investment Advisors Inc. boosted its position in shares of Genpact by 13.6% during the 3rd quarter. Tandem Investment Advisors Inc. now owns 2,936,194 shares of the business services provider's stock valued at $122,997,000 after acquiring an additional 351,871 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Genpact by 3.3% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,584,606 shares of the business services provider's stock valued at $108,269,000 after acquiring an additional 82,918 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the stock. Susquehanna set a $42.00 price target on shares of Genpact in a research note on Friday, February 6th. Weiss Ratings restated a "hold (c+)" rating on shares of Genpact in a research report on Friday, December 26th. Wall Street Zen upgraded Genpact from a "hold" rating to a "buy" rating in a research report on Saturday, January 10th. Needham & Company LLC reduced their price objective on Genpact from $53.00 to $50.00 and set a "buy" rating on the stock in a research note on Friday, February 6th. Finally, Mizuho lowered their price objective on Genpact from $51.00 to $49.00 and set a "neutral" rating for the company in a research note on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $47.29.
Check Out Our Latest Stock Report on G
Insiders Place Their Bets
In related news, CEO Balkrishan Kalra sold 2,800 shares of the business's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $40.77, for a total transaction of $114,156.00. Following the transaction, the chief executive officer directly owned 525,007 shares in the company, valued at $21,404,535.39. The trade was a 0.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Sameer Dewan sold 15,088 shares of the business's stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $46.65, for a total value of $703,855.20. Following the sale, the senior vice president owned 37,749 shares in the company, valued at $1,760,990.85. The trade was a 28.56% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 33,904 shares of company stock valued at $1,565,158. 3.07% of the stock is currently owned by insiders.
Genpact Stock Performance
Shares of NYSE:G opened at $41.71 on Friday. The firm's 50 day simple moving average is $42.84 and its 200-day simple moving average is $43.08. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.66 and a current ratio of 1.66. Genpact Limited has a one year low of $34.79 and a one year high of $52.03. The firm has a market cap of $7.08 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.20 and a beta of 0.75.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. Genpact had a return on equity of 22.02% and a net margin of 10.88%.The firm had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the previous year, the company posted $0.91 earnings per share. The firm's quarterly revenue was up 5.6% on a year-over-year basis. Genpact has set its FY 2026 guidance at 4.010-4.010 EPS and its Q1 2026 guidance at 0.920-0.930 EPS. As a group, equities analysts predict that Genpact Limited will post 3.21 EPS for the current year.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 16th will be paid a $0.1875 dividend. This represents a $0.75 annualized dividend and a yield of 1.8%. This is a positive change from Genpact's previous quarterly dividend of $0.17. The ex-dividend date is Monday, March 16th. Genpact's payout ratio is 21.73%.
About Genpact
(
Free Report)
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report